Effectiveness of ABRYSVO® Maternal Respiratory Syncytial Virus (RSV) Vaccine Against RSV in Infants in Western Pennsylvania

Clinical trial NCT06813872 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06813872
Sponsor: Pfizer
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Respiratory Syncytial Viruses

Start date: 2025-02-24
Primary completion: 2027-07-31
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.